Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR160080)
International Association for the Study of Lung Cancer
National Cancer Institute (CA195740, CA163896, CA205150, CA 196932, K08 CA163677, R01CA215075)
Received: 1 August 2018
Accepted: 9 January 2019
First Online: 6 February 2019
Ethics approval and consent to participate
: Human tissue specimen investigations were performed after approval by an institutional review board. Written informed consent was obtained on all patients.
: Not applicable.
: SP and WH are employees of Elstar Therapeutics. GD, and PSH are employees of Novartis Institutes for Biomedical Research.K.K.W. is a founder and equity holder of G1 Therapeutics and he has Consulting/Sponsored Research Agreements with AstraZeneca, Janssen, Pfizer, Array, Novartis, Merck, Takeda, TargImmune, Ono and BMS.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.